Symbolbild · KI-generiert
Neuropace, Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Neuropace develops implantable neurostimulation devices for the treatment of drug-resistant epilepsy. The lead product, the RNS System, detects abnormal brain activity and responds in real time with electrical impulses. The company markets its devices to specialist epilepsy centres in the United States.
Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Neuropace, Inc. | NPCE | NASDAQ | 439 Mio. USD |
| K-Bro Linen Inc. | KBL | TSX | 439 Mio. USD |
| Sagimet Biosciences Inc. Series A | SGMT | NASDAQ | 439 Mio. USD |
| Cabaletta Bio, Inc. | CABA | NASDAQ | 437 Mio. USD |
| Kyverna Therapeutics, Inc. | KYTX | NASDAQ | 444 Mio. USD |
| Pacific Biosciences of California, Inc. | PACB | NASDAQ | 435 Mio. USD |
| Tilray Brands Inc. | TLRY | TSX | 434 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.